Literature DB >> 27305321

Current Murine Models of Sepsis.

Anthony J Lewis1, Christopher W Seymour2, Matthew R Rosengart1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27305321      PMCID： PMC4960474          DOI： 10.1089/sur.2016.021

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN： 1096-2964            Impact factor:   2.150


× No keyword cloud information.
  91 in total

1.  Essential role of gamma interferon in survival of colon ascendens stent peritonitis, a novel murine model of abdominal sepsis.

Authors:  N Zantl; A Uebe; B Neumann; H Wagner; J R Siewert; B Holzmann; C D Heidecke; K Pfeffer
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

2.  Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture.

Authors:  D Remick; P Manohar; G Bolgos; J Rodriguez; L Moldawer; G Wollenberg
Journal:  Shock       Date:  1995-08       Impact factor: 3.454

3.  Genomic responses in mouse models greatly mimic human inflammatory diseases.

Authors:  Keizo Takao; Tsuyoshi Miyakawa
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

4.  Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity.

Authors:  D Newcomb; G Bolgos; L Green; D G Remick
Journal:  Shock       Date:  1998-08       Impact factor: 3.454

5.  Antibiotics improve survival and alter the inflammatory profile in a murine model of sepsis from Pseudomonas aeruginosa pneumonia.

Authors:  Craig M Coopersmith; Daniel M Amiot; Paul E Stromberg; W Michael Dunne; Christopher G Davis; Dale F Osborne; Kareem D Husain; Isaiah R Turnbull; Irene E Karl; Richard S Hotchkiss; Timothy G Buchman
Journal:  Shock       Date:  2003-05       Impact factor: 3.454

6.  Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.

Authors:  Rosa C S Vianna; Rachel N Gomes; Fernando A Bozza; Rodrigo T Amâncio; Patrícia T Bozza; Cid M N David; Hugo C Castro-Faria-Neto
Journal:  Shock       Date:  2004-02       Impact factor: 3.454

7.  Mortality and bacteriology of sepsis following cecal ligation and puncture in aged mice.

Authors:  S R Hyde; R D Stith; R E McCallum
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

8.  Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis.

Authors:  James L Wynn; Philip O Scumpia; Matthew J Delano; Kerri A O'Malley; Ricardo Ungaro; Amer Abouhamze; Lyle L Moldawer
Journal:  Shock       Date:  2007-12       Impact factor: 3.454

9.  Acute pyelonephritis and renal scarring are caused by dysfunctional innate immunity in mCxcr2 heterozygous mice.

Authors:  Majlis Svensson; Manisha Yadav; Bo Holmqvist; Nataliya Lutay; Catharina Svanborg; Gabriela Godaly
Journal:  Kidney Int       Date:  2011-08-03       Impact factor: 10.612

10.  Acute lung injury and acute kidney injury are established by four hours in experimental sepsis and are improved with pre, but not post, sepsis administration of TNF-α antibodies.

Authors:  Rhea Bhargava; Christopher J Altmann; Ana Andres-Hernando; Ryan G Webb; Kayo Okamura; Yimu Yang; Sandor Falk; Eric P Schmidt; Sarah Faubel
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240
View more
  72 in total

1.  Prompt Administration of Antibiotics and Fluids in the Treatment of Sepsis: A Murine Trial.

Authors:  Anthony J Lewis; John E Griepentrog; Xianghong Zhang; Derek C Angus; Christopher W Seymour; Matthew R Rosengart
Journal:  Crit Care Med       Date:  2018-05       Impact factor: 7.598

2.  Effect of Electroacupuncture on Urea and Creatinine Levels in the Wistar Sepsis Model.

Authors:  Darwin Harpin; Christina L Simadibrata; Hasan Mihardja; Atikah C Barasila
Journal:  Med Acupunct       Date:  2020-02-03

3.  Glucocorticoids limit lipopolysaccharide-induced lethal inflammation by a double control system.

Authors:  Kelly Van Looveren; Steven Timmermans; Tineke Vanderhaeghen; Charlotte Wallaeys; Marlies Ballegeer; Jolien Souffriau; Melanie Eggermont; Jolien Vandewalle; Lise Van Wyngene; Karolien De Bosscher; Claude Libert
Journal:  EMBO Rep       Date:  2020-05-08       Impact factor: 8.807

Review 4.  Can the Cecal Ligation and Puncture Model Be Repurposed To Better Inform Therapy in Human Sepsis?

Authors:  John C Alverdy; Robert Keskey; Renee Thewissen
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

5.  Endothelial Cells Exhibit Two Waves of P-selectin Surface Aggregation Under Endotoxic and Oxidative Conditions.

Authors:  Nathaly Barrionuevo; Sebastian Gatica; Pedro Olivares; Claudio Cabello-Verrugio; Felipe Simon
Journal:  Protein J       Date:  2019-12       Impact factor: 2.371

Review 6.  Translational Sepsis Research: Spanning the Divide.

Authors:  Anthony J Lewis; Janet S Lee; Matthew R Rosengart
Journal:  Crit Care Med       Date:  2018-09       Impact factor: 7.598

7.  Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activation.

Authors:  Liam M Casey; Sandeep Kakade; Joseph T Decker; Justin A Rose; Kyle Deans; Lonnie D Shea; Ryan M Pearson
Journal:  Biomaterials       Date:  2019-07-04       Impact factor: 12.479

Review 8.  Bench-to-Bedside: A Translational Perspective on Murine Models of Sepsis.

Authors:  Anthony J Lewis; Matthew R Rosengart
Journal:  Surg Infect (Larchmt)       Date:  2018-02-02       Impact factor: 2.150

9.  TMEM173 Drives Lethal Coagulation in Sepsis.

Authors:  Hui Zhang; Ling Zeng; Min Xie; Jiao Liu; Borong Zhou; Runliu Wu; Lizhi Cao; Guido Kroemer; Haichao Wang; Timothy R Billiar; Herbert J Zeh; Rui Kang; Jianxin Jiang; Yan Yu; Daolin Tang
Journal:  Cell Host Microbe       Date:  2020-03-05       Impact factor: 21.023

10.  Clinically relevant model of pneumococcal pneumonia, ARDS, and nonpulmonary organ dysfunction in mice.

Authors:  Jeffrey E Gotts; Olivier Bernard; Lauren Chun; Roxanne H Croze; James T Ross; Nicolas Nesseler; Xueling Wu; Jason Abbott; Xiaohui Fang; Carolyn S Calfee; Michael A Matthay
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-11       Impact factor: 5.464
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.